Back to Search
Start Over
Safety of cerebral angiography and neuroendovascular therapy in patients with chronic kidney disease
- Source :
- Neuroradiology. 60(5)
- Publication Year :
- 2017
-
Abstract
- Contrast-induced nephropathy is a common clinical concern in patients undergoing neuroendovascular procedures, especially in those with pre-existent kidney disease. We aimed to define the incidence of contrast-induced nephropathy in these high-risk patients in our practice. We analyzed data retrospectively from patients undergoing neuroendovascular procedures at two academic medical centers over a 4-year period. Contrast-induced nephropathy was determined by an absolute increase in serum creatinine of 0.5 mg/dL or a rise from its baseline value by ≥ 25%, at 48–72 h after exposure to contrast agent after excluding other causes of renal impairment. High-risk patients were identified as those with pre-procedural estimated glomerular filtration rate
- Subjects :
- Male
medicine.medical_specialty
Contrast-induced nephropathy
Urology
Renal function
Contrast Media
030204 cardiovascular system & hematology
Nephropathy
03 medical and health sciences
chemistry.chemical_compound
0302 clinical medicine
Triiodobenzoic Acids
medicine
Humans
Radiology, Nuclear Medicine and imaging
Renal Insufficiency, Chronic
Neuroradiology
Aged
Retrospective Studies
Creatinine
medicine.diagnostic_test
business.industry
Endovascular Procedures
Middle Aged
medicine.disease
Cerebral Angiography
chemistry
Angiography
Female
Neurology (clinical)
Patient Safety
Cardiology and Cardiovascular Medicine
business
030217 neurology & neurosurgery
Kidney disease
Cerebral angiography
Glomerular Filtration Rate
Subjects
Details
- ISSN :
- 14321920
- Volume :
- 60
- Issue :
- 5
- Database :
- OpenAIRE
- Journal :
- Neuroradiology
- Accession number :
- edsair.doi.dedup.....4b56bf972dd590fc2135225794fdd591